{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T02:48:27Z","timestamp":1764211707415},"reference-count":39,"publisher":"The Endocrine Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,12,1]]},"abstract":"<jats:p>Context: Cirrhosis after viral hepatitis has been identified as a risk factor for osteoporosis in men. However, in postmenopausal women, most studies have evaluated the effect of primary biliary cirrhosis, but little is known about the effect of viral cirrhosis on bone mass [bone mineral density (BMD)] and bone metabolism.<\/jats:p>\n               <jats:p>Objective: Our objective was to assess the effect of viral cirrhosis on BMD and bone metabolism in postmenopausal women.<\/jats:p>\n               <jats:p>Design: We conducted a cross-sectional descriptive study.<\/jats:p>\n               <jats:p>Setting and Patients: We studied 84 postmenopausal female outpatients with viral cirrhosis and 96 healthy postmenopausal women from the general community. BMD was measured by dual-energy x-ray absorptiometry at lumbar spine (LS) and femoral neck (FN).<\/jats:p>\n               <jats:p>Results: The percentage with osteoporosis did not significantly differ between patients (LS, 43.1%; FN, 32.2%) and controls (LS, 41.2%; FN, 29.4%), and there was no difference in BMD (z-score) between groups. Serum concentrations of soluble TNF receptors, estradiol, and osteoprotegerin (OPG) were significantly higher in patients vs. controls (P &amp;lt; 0.001, P &amp;lt; 0.05, and P &amp;lt; 0.05, respectively). No significant difference was observed in urinary deoxypyridinoline. Serum OPG levels were positively correlated with soluble TNF receptors (r = 0.35; P &amp;lt; 0.02) and deoxypyridinoline (r = 0.37; P &amp;lt; 0.05).<\/jats:p>\n               <jats:p>Conclusions: This study shows that bone mass and bone resorption rates do not differ between postmenopausal women with viral cirrhosis and healthy postmenopausal controls and suggests that viral cirrhosis does not appear to increase the risk of osteoporosis in these women. High serum estradiol and OPG concentrations may contribute to preventing the bone loss associated with viral cirrhosis in postmenopausal women.<\/jats:p>\n               <jats:p>High serum estradiol and osteoprotegerin concentrations may contribute to preventing the bone loss associated with viral cirrhosis in postmenopausal women.<\/jats:p>","DOI":"10.1210\/jc.2009-0835","type":"journal-article","created":{"date-parts":[[2009,11,7]],"date-time":"2009-11-07T03:03:17Z","timestamp":1257562997000},"page":"4844-4850","source":"Crossref","is-referenced-by-count":42,"title":["Bone Mineral Density and Serum Levels of Soluble Tumor Necrosis Factors, Estradiol, and Osteoprotegerin in Postmenopausal Women with Cirrhosis after Viral Hepatitis"],"prefix":"10.1210","volume":"94","author":[{"given":"Jorge L.","family":"Gonza\u0301lez-Calvin","sequence":"first","affiliation":[{"name":"Department of Gastroenterology (J.L.G.-C., J.L.M., F.J.C.-C., A.C.A., J.J.M.-I.), University Hospital San Cecilio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose L.","family":"Mundi","sequence":"first","affiliation":[{"name":"Department of Gastroenterology (J.L.G.-C., J.L.M., F.J.C.-C., A.C.A., J.J.M.-I.), University Hospital San Cecilio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco J.","family":"Casado-Caballero","sequence":"first","affiliation":[{"name":"Department of Gastroenterology (J.L.G.-C., J.L.M., F.J.C.-C., A.C.A., J.J.M.-I.), University Hospital San Cecilio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana C.","family":"Abadia","sequence":"first","affiliation":[{"name":"Department of Gastroenterology (J.L.G.-C., J.L.M., F.J.C.-C., A.C.A., J.J.M.-I.), University Hospital San Cecilio"},{"name":"Department of Biochemistry and Molecular Biology III and Immunology (A.C.A.), University of Granada, 18001 Granada Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose J.","family":"Martin-Iban\u0303ez","sequence":"first","affiliation":[{"name":"Department of Gastroenterology (J.L.G.-C., J.L.M., F.J.C.-C., A.C.A., J.J.M.-I.), University Hospital San Cecilio"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"2020071613053088400_R1","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/gut.31.1.82","article-title":"Osteoporosis and skeletal fractures in chronic liver disease.","volume":"31","author":"Diamond","year":"1990","journal-title":"Gut"},{"key":"2020071613053088400_R2","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/hep.510280315","article-title":"Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis.","volume":"28","author":"Gallego-Rojo","year":"1998","journal-title":"Hepatology"},{"key":"2020071613053088400_R3","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1210\/jc.2004-0077","article-title":"Osteoporosis, mineral metabolism, and serum soluble tumor necrosis factor receptor p55 in viral cirrhosis.","volume":"89","author":"Gonzalez-Calvin","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613053088400_R4","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0016-5085(03)01062-X","article-title":"American Gastroenterological Association Clinical Practice Committee. AGA technical review on osteoporosis in hepatic disorders.","volume":"125","author":"Leslie","year":"2003","journal-title":"Gastroenterology"},{"key":"2020071613053088400_R5","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s002239900545","article-title":"Risk factors for the development of vertebral and total skeleton osteoporosis in patients with primary biliary cirrhosis.","volume":"63","author":"Bagur","year":"1998","journal-title":"Calcif Tissue Int"},{"key":"2020071613053088400_R6","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/BF02365443","article-title":"Osteopenia in primary biliary cirrhosis and cirrhosis of the liver in women, evaluated by dual-energy x-ray absorptiometry.","volume":"29","author":"Shiomi","year":"1994","journal-title":"J Gastroenterol"},{"key":"2020071613053088400_R7","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s00198-003-1495-z","article-title":"The heterogeneity of bone disease in cirrhosis: a multivariate analysis.","volume":"14","author":"Crawford","year":"2003","journal-title":"Osteoporos Int"},{"key":"2020071613053088400_R8","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/gut.50.suppl_1.i1","article-title":"Guidelines on the management of osteoporosis associated with chronic liver disease","volume":"50","author":"Collier","year":"2002","journal-title":"Gut"},{"key":"2020071613053088400_R9","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/hep.1840130211","article-title":"Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients.","volume":"13","author":"Khoruts","year":"1991","journal-title":"Hepatology"},{"key":"2020071613053088400_R10","first-page":"319","article-title":"Tumour necrosis factor, interleukin-1 and interleukin-6 in alcoholic cirrhosis.","volume":"28","author":"Diez Ruiz","year":"1993","journal-title":"Alcohol Alcohol"},{"key":"2020071613053088400_R11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1515\/pteridines.2000.11.2.43","article-title":"Neopterin, soluble receptors for interleukin-2 and tumor necrosis factor in viral cirrhosis and alcoholic cirrhosis.","volume":"11","author":"Gonzalez-Calvin","year":"2000","journal-title":"Pteridines"},{"key":"2020071613053088400_R12","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/jbmr.5650110802","article-title":"Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis.","volume":"11","author":"Pacifici","year":"1996","journal-title":"J Bone Miner Res"},{"key":"2020071613053088400_R13","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S8756-3282(99)00162-3","article-title":"Interleukin-1\u03b2 and tumor necrosis factor-\u03b1, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells.","volume":"25","author":"Hofbauer","year":"1999","journal-title":"Bone"},{"key":"2020071613053088400_R14","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1172\/JCI11176","article-title":"TNF-\u03b1 induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand.","volume":"106","author":"Lam","year":"2000","journal-title":"J Clin Invest"},{"key":"2020071613053088400_R15","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/nm1096-1132","article-title":"Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-\u03b2.","volume":"2","author":"Hughes","year":"1996","journal-title":"Nat Med"},{"key":"2020071613053088400_R16","doi-asserted-by":"crossref","first-page":"7829","DOI":"10.1073\/pnas.130200197","article-title":"Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression.","volume":"97","author":"Shevde","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071613053088400_R17","doi-asserted-by":"crossref","first-page":"8836","DOI":"10.1074\/jbc.M010764200","article-title":"Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-\u03baB ligand (RANKL)-induced JNK activation.","volume":"276","author":"Srivastava","year":"2001","journal-title":"J Biol Chem"},{"key":"2020071613053088400_R18","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1172\/JCI200317215","article-title":"Role of RANK ligand in mediating increased bone resorption in early postmenopausal women.","volume":"111","author":"Eghbali-Fatourechi","year":"2003","journal-title":"J Clin Invest"},{"key":"2020071613053088400_R19","doi-asserted-by":"crossref","first-page":"20959","DOI":"10.1074\/jbc.C000290200","article-title":"Osteoprotegerin is an \u03b1v\u03b23-induced, NF-\u03baB-dependent survival factor for endothelial cells","volume":"275","author":"Malyankar","year":"2000","journal-title":"J Biol Chem"},{"key":"2020071613053088400_R20","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1210\/endo.140.9.7131","article-title":"Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells.","volume":"140","author":"Hofbauer","year":"1999","journal-title":"Endocrinology"},{"key":"2020071613053088400_R21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0168-8278(91)90859-A","article-title":"Menopausal age and sex hormones in postmenopausal women with alcoholic and non-alcoholic liver disease.","volume":"13","author":"Becker","year":"1991","journal-title":"J Hepatol"},{"key":"2020071613053088400_R22","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/bjs.1800600817","article-title":"Transection of the oesophagus for bleeding oesophageal varices.","volume":"60","author":"Pugh","year":"1973","journal-title":"Br J Surg"},{"key":"2020071613053088400_R23","first-page":"757","article-title":"Reliability and validity of commercially available, direct radioimmunoassay for measurements of blood androgens and estrogens in postmenopausal women.","volume":"10","author":"Rinaldi","year":"2001","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"2020071613053088400_R24","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1210\/jcem.82.6.4026","article-title":"Antiresorptive therapy in hyperthyroid patients: longitudinal changes in bone and mineral metabolism.","volume":"82","author":"Jo\u0301dar","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613053088400_R25","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/BF01623462","article-title":"Study of bone mineral density in lumbar spine and femoral neck in a Spanish population. Multicentre Research Project on Osteoporosis.","volume":"7","author":"Diaz Curiel","year":"1997","journal-title":"Osteoporos Int"},{"key":"2020071613053088400_R26","year":"1994"},{"key":"2020071613053088400_R27","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1007\/s00198-005-1844-1","article-title":"The contribution of serum osteoprotegerin to bone mass and vertebral fractures in postmenopausal women.","volume":"16","author":"Mezquita-Raya","year":"2005","journal-title":"Osteoporos Int"},{"key":"2020071613053088400_R28","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s00198-004-1680-8","article-title":"Osteoporosis is markedly underdiagnosed: a nationwide study from Denmark.","volume":"16","author":"Vestergaard","year":"2005","journal-title":"Osteoporos Int"},{"key":"2020071613053088400_R29","first-page":"571","article-title":"Mineral metabolism, osteoblastic function and bone mass in chronic alcoholism.","volume":"28","author":"Gonzalez-Calvi\u0301n","year":"1993","journal-title":"Alcohol Alcohol"},{"key":"2020071613053088400_R30","first-page":"449","article-title":"Effect of acute alcohol ingestion on mineral metabolism and osteoblastic function.","volume":"30","author":"Garci\u0301a-Sanchez","year":"1995","journal-title":"Alcohol Alcohol"},{"key":"2020071613053088400_R31","first-page":"1416","article-title":"Effect of alcohol consumption on adult bone mineral density and bone turnover markers.","volume":"23","author":"Gonzalez-Calvin","year":"1999","journal-title":"Alcohol Clin Exp Res"},{"key":"2020071613053088400_R32","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/oxfordjournals.aje.a117664","article-title":"Alcohol intake and bone mineral density in elderly men and women. The Framingham Study.","volume":"142","author":"Felson","year":"1995","journal-title":"Am J Epidemiol"},{"key":"2020071613053088400_R33","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1136\/bmj.306.6891.1506","article-title":"A prospective study of alcohol consumption and bone mineral density.","volume":"306","author":"Holbrook","year":"1993","journal-title":"BMJ"},{"key":"2020071613053088400_R34","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1530-0277.1993.tb00842.x","article-title":"Alcohol and estrogen levels in postmenopausal women: the spectrum of effect.","volume":"17","author":"Gavaler","year":"1993","journal-title":"Alcohol Clin Exp Res"},{"key":"2020071613053088400_R35","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1053\/j.gastro.2004.02.047","article-title":"Bone mineral density and serum levels of estradiol and osteoprotegerin in postmenopausal women with viral cirrhosis","volume":"126","author":"Gonzalez-Calvin","year":"2004","journal-title":"Gastroenterology"},{"key":"2020071613053088400_R36","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1359\/jbmr.1999.14.4.518","article-title":"Immunological characterization of circulating osteoprotegerin\/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis.","volume":"14","author":"Yano","year":"1999","journal-title":"J Bone Miner Res"},{"key":"2020071613053088400_R37","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1530\/eje.0.1320251","article-title":"New markers of bone metabolism: clinical use in metabolic bone disease.","volume":"132","author":"Eriksen","year":"1995","journal-title":"Eur J Endocrinol"},{"key":"2020071613053088400_R38","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1136\/gut.32.11.1303","article-title":"Osteopenia and osteomalacia after gastrectomy: interrelations between biochemical markers of bone remodelling, vitamin D metabolites, and bone histomorphometry.","volume":"32","author":"Bisballe","year":"1991","journal-title":"Gut"},{"key":"2020071613053088400_R39","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/8756-3282(88)90037-3","article-title":"Effects of bone associated growth factors on DNA, collagen and osteocalcin synthesis in cultured fetal rat calvariae.","volume":"9","author":"Canalis","year":"1988","journal-title":"Bone"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/94\/12\/4844\/11059810\/jcem4844.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/94\/12\/4844\/11059810\/jcem4844.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T22:57:27Z","timestamp":1594940247000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/94\/12\/4844\/2596743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,1]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,12,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2009-0835","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,1]]}}}